CD276 and adrenal cortex carcinoma: In addition, N6AMT1 expression had pan-cancer correlations with most of the 45 immunostimulators: in ACC, N6AMT1 expression showed the strongest positive correlation with CXCR4; in UVM, N6AMT1 expression showed the strongest negative correlation with CD276 (Figure 7B).